Randolf Kerschbaumer

Randolf Kerschbaumer

Company: OncoOne

Job title: Chief Executive Officer

Seminars:

Targeting the Oxidized Macrophage Migration Inhibitory Factor (oxMIF) in Inflammation and its Link to Oncology 4:00 pm

oxMIF is the disease-related and druggable isoform of the macrophage migration inhibitory factor ON104 is an optimized antibody targeting oxMIF for the treatment of patients with inflammatory conditions oxMIF provides a critical link between inflammation and immuno-oncologyRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.